Literature DB >> 14685874

Role of growth factors and the wound healing response in age-related macular degeneration.

Reinier O Schlingemann1.   

Abstract

Growth factors (GF) are important in several stages of the pathogenesis of age-related macular disease (AMD). In choroidal neovascularization (CNV) in exudative AMD, the GF involved are similar to those involved in wound healing of the skin. Like granulation tissue of skin, CNV is characterized by clotting, inflammation, angiogenesis and fibrosis, and like in skin wounds, members of the VEGF, angiopoietin, PDGF and TGF-beta families of GF are expressed. However, several of these GF may also serve physiological functions in the normal eye, where the retinal pigment epithelium (RPE) employs them to provide trophic support to the neuroretina and choriocapillaris, in addition to maintaining an anti-angiogenic state. Derangement of these physiological functions may underlie the initiation of CNV in AMD. Basolateral secretion of VEGF-A by the RPE maintains the choriocapillaris, and is enhanced by hypoxia. Age-related changes in Bruch's membrane lead to impairment of this trophic function and choriocapillaris atrophy, as well as to decreased diffusion of oxygen towards the neuroretina. The resulting outer retina hypoxia may be an important driving force of CNV formation, by stimulating VEGF overexpression by the RPE, in addition to the effects of increased oxidative stress and low-grade inflammation. RPE senescence and hypoxia may also decrease expression of angiogenesis inhibitors such as PEDF, further shifting the balance to a pro-angiogenic state in the aging eye.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14685874     DOI: 10.1007/s00417-003-0828-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  74 in total

1.  Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes.

Authors:  A Otani; H Takagi; H Oh; S Koyama; M Matsumura; Y Honda
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-08       Impact factor: 4.799

2.  Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells.

Authors:  H Miyajima-Uchida; H Hayashi; R Beppu; M Kuroki; M Fukami; F Arakawa; Y Tomita; M Kuroki; K Oshima
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-02       Impact factor: 4.799

3.  Bone morphogenetic proteins-2 and -4: negative growth regulators in adult retinal pigmented epithelium.

Authors:  J R Mathura; N Jafari; J T Chang; S F Hackett; K J Wahlin; N G Della; N Okamoto; D J Zack; P A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-02       Impact factor: 4.799

4.  Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue.

Authors:  R O Schlingemann; F J Rietveld; F Kwaspen; P C van de Kerkhof; R M de Waal; D J Ruiter
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

5.  Time-course expression of vascular endothelial growth factor as related to the development of the retinochoroidal vasculature in rats.

Authors:  X Yi; L C Mai; M Uyama; D T Yew
Journal:  Exp Brain Res       Date:  1998-01       Impact factor: 1.972

Review 6.  Vascular endothelial growth factors and angiogenesis in eye disease.

Authors:  A N Witmer; G F J M Vrensen; C J F Van Noorden; R O Schlingemann
Journal:  Prog Retin Eye Res       Date:  2003-01       Impact factor: 21.198

Review 7.  The role of oxidative stress in the pathogenesis of age-related macular degeneration.

Authors:  S Beatty; H Koh; M Phil; D Henson; M Boulton
Journal:  Surv Ophthalmol       Date:  2000 Sep-Oct       Impact factor: 6.048

8.  The role of adult bone marrow-derived stem cells in choroidal neovascularization.

Authors:  Nilanjana Sengupta; Sergio Caballero; Robert N Mames; Jason M Butler; Edward W Scott; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

Review 9.  Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders.

Authors:  Aernout Luttun; Marc Tjwa; Peter Carmeliet
Journal:  Ann N Y Acad Sci       Date:  2002-12       Impact factor: 5.691

10.  Hypoxic regulation of vascular endothelial growth factor in retinal cells.

Authors:  L P Aiello; J M Northrup; B A Keyt; H Takagi; M A Iwamoto
Journal:  Arch Ophthalmol       Date:  1995-12
View more
  98 in total

Review 1.  The stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocity.

Authors:  D Kent
Journal:  Eye (Lond)       Date:  2015-07-31       Impact factor: 3.775

2.  Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization.

Authors:  Alexander V Ljubimov; Sergio Caballero; Annette M Aoki; Lorenzo A Pinna; Maria B Grant; Raquel Castellon
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-12       Impact factor: 4.799

3.  Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes.

Authors:  Olcay Tatar; Kei Shinoda; Annemarie Adam; Tillmann Eckert; Claus Eckardt; Klaus Lucke; Christoph Deuter; Karl Ulrich Bartz-Schmidt; Salvatore Grisanti
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

4.  Imaging polarimetry in patients with neovascular age-related macular degeneration.

Authors:  Ann E Elsner; Anke Weber; Michael C Cheney; Dean A VanNasdale; Masahiro Miura
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2007-05       Impact factor: 2.129

Review 5.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

6.  Rac1 activates HIF-1 in laser induced choroidal neovascularization.

Authors:  Peng Zhang; Xing Zhang; Jiang-Li Fan; Xiao-Feng Hao; Yu-Sheng Wang; Yan-Nian Hui; Dan Hu; Jian Zhou
Journal:  Int J Ophthalmol       Date:  2011-02-18       Impact factor: 1.779

7.  Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells.

Authors:  Swaantje Peters; Sylvie Julien; Peter Heiduschka; Salvatore Grisanti; Focke Ziemssen; Martin Adler; Ulrich Schraermeyer; Karl-Ulrich Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

8.  Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy.

Authors:  Olcay Tatar; Annemarie Adam; Kei Shinoda; Tillmann Eckert; Gábor B Scharioth; Micheal Klein; Efdal Yoeruek; Karl Ulrich Bartz-Schmidt; Salvatore Grisanti
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

9.  Connective tissue growth factor as a mediator of intraocular fibrosis.

Authors:  Shikun He; Youxin Chen; Rima Khankan; Ernesto Barron; Richard Burton; Danhong Zhu; Stephen J Ryan; Noelynn Oliver; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

10.  Functional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuity.

Authors:  Beatrix Feigl; Amanda Greaves; Brian Brown
Journal:  Clin Ophthalmol       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.